The 2011 Gordon Research Conference on Tuberculosis Drug Development will cover the range of activities involved in discovering and producing new drugs. With the realization that target-based screening for anti-bacterial agents has been disappointing, and that druggable targets are scarce, this GRC will also reassess the approaches involved. The conference will present new enabling technologies, address target and compound discovery, discuss new candidate drugs in development, highlight clinical trial design and share early trial results while also considering alternative approaches to tuberculosis treatment. We invite researchers interested in all of these aspects of drug development to attend and welcome participants from academia, industry, government and non-governmental organizations. In particular, we invite trainees and scientists from TB-endemic countries to apply as their contribution to the struggle against TB is especially important. All participants are asked to submit abstracts of their work for presentation as posters and some of these abstracts will be chosen for oral presentations. The conference provides the opportunity to interact with colleagues in an informal and intimate atmosphere and is designed to promote extensive discussion. In the past, the meeting has been oversubscribed - please apply early!